Denali Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Denali Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Denali Therapeutics Inc
Rating: 1.94725
Author: Trendlyne DVM scores

about

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant ...

20.31 -0.62 (-2.96%)

92.15% Gain from 52W Low

1.4M

XNAS Volume

XNAS 23 Jan, 2026 3:16 PM (EST)

Not Eligible

Expensive Valuation

8.0 / 100

Technically Moderately Bullish

69.9 / 100

1Yr Price target upside is 91%

14 analysts

Denali Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Denali Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant ...

92.15% Gain from 52W Low

SWOT Analysis

Denali Therapeutics Inc Live Price Chart